1. Home
  2. DGII vs HCM Comparison

DGII vs HCM Comparison

Compare DGII & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digi International Inc.

DGII

Digi International Inc.

HOLD

Current Price

$66.66

Market Cap

2.6B

Sector

Technology

ML Signal

HOLD

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

HOLD

Current Price

$11.04

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGII
HCM
Founded
1985
2000
Country
United States
Hong Kong
Employees
N/A
1796
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.3B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
DGII
HCM
Price
$66.66
$11.04
Analyst Decision
Strong Buy
Sell
Analyst Count
5
1
Target Price
$48.80
$13.75
AVG Volume (30 Days)
443.6K
50.9K
Earning Date
05-06-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
77.05
N/A
EPS
0.60
N/A
Revenue
$430,221,000.00
N/A
Revenue This Year
$18.71
$20.60
Revenue Next Year
$7.22
$15.62
P/E Ratio
$109.67
$5.49
Revenue Growth
1.46
N/A
52 Week Low
$30.69
$9.77
52 Week High
$76.41
$19.50

Technical Indicators

Market Signals
Indicator
DGII
HCM
Relative Strength Index (RSI) 47.78 47.58
Support Level $65.23 $10.83
Resistance Level $70.30 $11.80
Average True Range (ATR) 2.77 0.23
MACD -0.42 0.01
Stochastic Oscillator 45.72 16.67

Price Performance

Historical Comparison
DGII
HCM

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: